Stealthy biotech buys up patent portfolios in string of recent deals
Terran Biosciences has emerged from obscurity to snap up slew of IP rights in the past two months
Terran Biosciences has emerged from obscurity to snap up slew of IP rights in the past two months
NortonLifeLock has pledged to appeal the jury verdict, which could balloon to $550 million with enhanced damages for wilful infringement
Following major US CRISPR decision, Michael Arciero, VP of IP at ERS Genomics, tells IAM that tricky patent landscapes are the new normal in biotech
$3.2 billion Sanofi deal is unlikely to be the last as Big Pharma seeks to consolidate its position in the cutting-edge field
12 August 2021
There are a lot of potential benefits to the new system, but we need to integrate it into our strategies to make sure it works, explains Joerg Thomaier
11 August 2021
The company is hoping to raise cash to help expand its purchasing power when acquiring pharmaceuticals revenue streams
05 August 2021
The Virginia-based R&D outfit has made a string of sales to big names in consumer tech over recent months, with Samsung another prominent customer
26 July 2021
Country’s National Health Service fails to overturn rules on damages sought by healthcare providers affected by failed enforcement
07 July 2021
In a 5-4 decision the court’s justices significantly narrowed the scope of the doctrine that prevents assignors from challenging patents in court.
01 July 2021
Apollo Therapeutics is an innovative biotech formed by three UK universities and three major companies, with a promising model for creating and monetising life sciences IP
29 June 2021
With text-based discussions of a TRIPS suspension about to get underway, IAM highlights the key issues to be aware of.
17 June 2021
Partnership agreements are a growing part of the biopharma R&D process, so anticipating potential pitfalls in such arrangements is vital
14 June 2021
The Strategic Competition Act of 2021 could also see increased use of sanctions to combat IP theft
28 April 2021
Get unlimited access to all IAM content